Johnson & Johnson products for sale in New York.

Scott Mlyn | CNBC

Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of the split, Morgan Stanley put out a research note, highlighting some of the debates in the market over the move, which would result in a consumer brands company called Kenvue and a pharma company with the J&J moniker.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *